GlaxoSmithKline plc ADR

Historical 13F Holders

Symbol
GSK
CUSIP
37733W105
All holders as of
Q3 2025
Type
Equity
Class
SPONSORED ADR
Reported Value, Excluding Options
Total Filings
Period Filings Shares, Excl. Options Value, Excl. Options
2025 Q3 5 2.10 k $90.7 k
2025 Q2 5 2.42 k $93.0 k
2025 Q1 6 825 k $31.9 M
2024 Q4 6 887 k $30.0 M
2024 Q3 7 1.09 M $44.4 M
2024 Q2 7 1.27 M $48.9 M
2024 Q1 9 1.28 M $54.9 M
2023 Q4 8 1.27 M $47.1 M
2023 Q3 9 1.30 M $47.0 M
2023 Q2 9 1.29 M $45.5 M
2023 Q1 9 1.29 M $45.9 M
2022 Q4 13 1.31 M $46.4 M
2022 Q3 36 2.70 M $79.8 M
2022 Q2 879 339 M $15.6 B
2022 Q1 974 333 M $14.5 B
2021 Q4 968 328 M $14.5 B
2021 Q3 828 324 M $12.4 B
2021 Q2 833 320 M $12.7 B
2021 Q1 811 317 M $11.3 B
2020 Q4 868 306 M $11.3 B
2020 Q3 865 299 M $11.2 B
2020 Q2 882 306 M $12.5 B
2020 Q1 856 314 M $11.9 B
2019 Q4 936 297 M $13.9 B
2019 Q3 843 283 M $12.1 B
2019 Q2 852 286 M $11.5 B
2019 Q1 888 281 M $11.7 B
2018 Q4 835 276 M $10.5 B
2018 Q3 825 275 M $11.0 B
2018 Q2 830 277 M $11.1 B
2018 Q1 821 276 M $10.8 B
2017 Q4 802 273 M $9.69 B
2017 Q3 776 243 M $9.85 B
2017 Q2 816 230 M $9.90 B
2017 Q1 827 225 M $9.51 B
2016 Q4 808 214 M $8.23 B
2016 Q3 781 207 M $8.93 B
2016 Q2 785 215 M $9.52 B
2016 Q1 763 205 M $8.35 B
2015 Q4 771 217 M $8.80 B
2015 Q3 750 220 M $8.42 B
2015 Q2 770 235 M $9.75 B
2015 Q1 779 251 M $11.7 B
2014 Q4 781 255 M $21.1 B
2014 Q3 744 265 M $12.3 B
2014 Q2 755 286 M $15.4 B
2014 Q1 747 262 M $14.1 B